Cure8 research brief
Why This Matters
Findings are relevant because they describe outcomes and predictors of conversion for a minimally invasive surgery option (SILS) that some patients with Crohn's disease may be offered. Understanding risk factors can help with surgical planning and setting expectations.
Who Should Pay Attention
Surgeons and surgical teams treating Crohn's disease, gastroenterologists involved in surgical referral decisions, patients planning intestinal resection (especially those with fistula or colon disease), and researchers studying minimally invasive surgical techniques.
Study Snapshot
What To Know
This retrospective analysis of 289 Crohn's patients treated with an SILS-first strategy found an overall conversion rate to open surgery of 11.8%. Independent predictors of conversion were presence of a fistula, colon resection, and a smoking history.
Patients who converted had longer operations and more blood loss, but similar postoperative complication rates and hospital length of stay compared with those who completed SILS.
Practical takeaways: The authors conclude SILS-first can be used safely with a relatively low conversion rate, and that surgeons should be prepared to add ports or convert when risk factors (fistula, colon involvement, smoking) are present. This supports a staged port-escalation approach rather than attempting prolonged single-incision attempts.
Keep In Mind
Structured content depth: abstract. This summary is based on the article abstract and reported retrospective cohort data; it does not replace reading the full paper for detailed methods, patient selection, or subgroup analyses. Retrospective design can introduce selection bias and limits causal inference.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.